---
figid: PMC5412337__ijms-18-00752-g001
figtitle: Current strategies for targeting the epidermal growth factor receptor (EGFR)
  pathway
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5412337
filename: ijms-18-00752-g001.jpg
figlink: /pmc/articles/PMC5412337/figure/ijms-18-00752-f001/
number: F1
caption: 'Current strategies for targeting the epidermal growth factor receptor (EGFR)
  pathway. EGF receptors (Blue) activate survival signaling pathways including RAS/MAPK
  and PI3K/AKT signaling pathway leading to cell growth and proliferation. HGF/MET
  (green) signaling also promotes cell growth and proliferation through RAS/MAPK and
  STAT3 phosphorylation. Regular arrow: activates, Arrow ending with a straight line:
  inhibits.'
papertitle: Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment
  of Metastatic Colorectal Cancer.
reftext: Yuji Miyamoto, et al. Int J Mol Sci. 2017 Apr;18(4):752.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9362032
figid_alias: PMC5412337__F1
figtype: Figure
redirect_from: /figures/PMC5412337__F1
ndex: c75c1fd5-df07-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5412337__ijms-18-00752-g001.html
  '@type': Dataset
  description: 'Current strategies for targeting the epidermal growth factor receptor
    (EGFR) pathway. EGF receptors (Blue) activate survival signaling pathways including
    RAS/MAPK and PI3K/AKT signaling pathway leading to cell growth and proliferation.
    HGF/MET (green) signaling also promotes cell growth and proliferation through
    RAS/MAPK and STAT3 phosphorylation. Regular arrow: activates, Arrow ending with
    a straight line: inhibits.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Akt
  - Dsor1
  - Mtk
  - Mtor
  - Tor
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - EGF
  - HGF
  - IL6
  - SOS1
  - RNMT
  - KRAS
  - HRAS
  - NRAS
  - STAT3
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - BMS-908662
  - Selumetinib
  - Tivantinib
  - Trametinib
  - Dabrafenib
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
